Quantum量子訊息有限公司

Asia Pacific Medical Foods Market

研究執行與發布：Grand View Research　·　發布日期 2026-08-31　·　120 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

申請 Sample
完整報告名稱與涵蓋範圍
Asia Pacific Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Enteral), By Product (Powder, Pills, Liquid), By Application (Diabetic Neuropathy, ADHD), By Modules, By Sales Channel, By Country, And Segment Forecasts, 2026 - 2033

報告摘要

Asia Pacific Medical Foods Market Summary The Asia Pacific medical foods market size was valued at USD 7.3 billion in 2025 and is projected to grow from USD 7.8 billion in 2026 to USD 11.9 billion by 2033, at a CAGR of 6.2% from 2026 to 2033. China dominated the market, accounting for the largest revenue share of 33.0% in 2025. The region has a large patient pool and geriatric population, and lifestyle changes are leading to an increase in the prevalence of various diseases, such as cancer, diabetes, gastrointestinal disorders, & autoimmune diseases. According to data published by the WHO in February 2023, Thailand had 12 million elderly people out of a population of 67 million, with the elderly population expected to reach 28% within the next decade, increasing the demand for medical foods to address age-related nutritional needs. Asia Pacific Medical Food Market Report Segmentation This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Asia Pacific medical foods market report based on route of administration, product, application, modules, sales channel, and country: • Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033) • Oral • Enteral • Product Outlook (Revenue, USD Billion, 2021 - 2033) • Pills • Powder • Liquid • Others (semisolid, semiliquid) • Application Outlook (Revenue, USD Billion, 2021 - 2033) • Chronic Kidney Disease • Minimal Hepatic Encephalopathy • Chemotherapy Induced Diarrhoea • Pathogen Related Infections • Diabetic Neuropathy • ADHD • Depression • Alzheimer's Disease • Nutritional Deficiency • Orphan Diseases o Tyrosinemia o Eosinophilic Esophagitis o Food Protein Module-induced enterocolitis syndrome (Food Protein Module-induced enterocolitis syndrome (FPIES)) o Phenylketonuria (PKU) o Maple syrup urine disease (Maple syrup urine disease (MSUD)) o Homocystinuria o Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.) • Wound Healing • Chronic Diarrhea • Constipation Relief • Protein Booster • Dysphagia • Pain Management • Parkinson's Disease • Epilepsy • Other Cancer related treatments • Severe Protein Allergy • Cancer • Cachexia • Other (debilitating conditions, COPD, etc.) • Modules Outlook (Revenue, USD Billion, 2021 - 2033) • Amino Acid Module • Protein Module • Vitamin & Mineral Modules • Fatty Acid based Modules • Carbohydrate Modules • Fiber Modules • Ketogenic Modules • Peptide based Modules • Hypoallergic Modules • Others (Electrolyte Module, etc.) • Sales Channel Outlook (Revenue, USD Billion, 2021 - 2033) • DTC Sales Channel o Online Sales o Retail Sales • Institutional Sales o Hospitals o Others (Long-term Care Facilities, etc.) • Country Outlook (Revenue, USD Billion, 2021 - 2033) • Japan • China • Australia • India • South Korea • Thailand • Vietnam • Malaysia • Indonesia • Singapore

授權報價

Single User License$5,950 USD
Enterprise License$6,950 USD
Corporate User License$8,950 USD

目錄 Table of Contents

Table of Contents Chapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Route of Administration 1.1.2. Product 1.1.3. Application 1.1.4. Modules 1.1.5. Sales Channel 1.1.6. Country scope 1.2. Estimates and forecast timeline 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased database. 1.4.2. GVR’s internal database 1.4.3. Secondary sources 1.4.4. Primary research 1.4.5. Details of primary research 1.5. Information or Data Analysis 1.5.1. Data analysis models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity flow analysis (Model 1) 1.7.2. Approach 1: Commodity flow approach 1.8. List of Secondary Sources 1.9. List of Primary Sources 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Route of administration outlook 2.2.2. Product outlook 2.2.3. Application outlook 2.2.4. Modules outlook 2.2.5. Sales channel outlook 2.2.6. Country outlook 2.3. Competitive Insights Chapter 3. Asia Pacific Medical Foods Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Supportive Government Initiatives and Strengthening Regulatory Frameworks for Medical Foods 3.2.1.2. Growing Geriatric Population and Chronic Disease Burden 3.2.1.3. Rising Nutritional Deficiencies and Malnutrition 3.2.2. Market Restraint Analysis 3.2.2.1. Reimbursement and Insurance Limitations 3.2.2.2. High Cost of Medical Foods 3.3. Regulatory Framework 3.4. Notable Trends in the Region 3.5. Pricing Analysis (Company level product pricing) 3.6. Notable Initiatives To Support the Market 3.7. Asia Pacific Medical Foods Market Analysis Tools 3.7.1. Industry Analysis - Porter’s Five Forces 3.7.1.1. Supplier power 3.7.1.2. Buyer power 3.7.1.3. Substitution threat 3.7.1.4. Threat of new entrant 3.7.1.5. Competitive rivalry 3.7.2. PESTEL Analysis 3.7.2.1. Political landscape 3.7.2.2. Economic landscape 3.7.2.3. Social landscape 3.7.2.4. Technological landscape 3.7.2.5. Environmental landscape 3.7.2.6. Legal landscape Chapter 4. Asia Pacific Medical Foods Market: Route of Administration Estimates & Trend Analysis 4.1. Route of Administration Market Share, 2025 & 2033 4.2. Segment Dashboard 4.3. Asia Pacific Medical Foods Market by Route of Administration Outlook 4.4. Oral 4.4.1. Market estimates and forecast 2021 to 2033 (USD Billion) 4.5. Enteral 4.5.1. Market estimates and forecast 2021 to 2033 (USD Billion) Chapter 5. Asia Pacific Medical Foods Market: Product Estimates & Trend Analysis 5.1. Product Market Share, 2025 & 2033 5.2. Segment Dashboard 5.3. Asia Pacific Medical Foods Market by Product Outlook 5.4. Pills 5.4.1. Market estimates and forecast 2021 to 2033 (USD Billion) 5.5. Powder 5.5.1. Market estimates and forecast 2021 to 2033 (USD Billion) 5.6. Liquid 5.6.1. Market estimates and forecast 2021 to 2033 (USD Billion) 5.7. Others (semisolid, semiliquid) 5.7.1. Market estimates and forecast 2021 to 2033 (USD Billion) Chapter 6. Asia Pacific Medical Foods Market: Application Estimates & Trend Analysis 6.1. Application Market Share, 2025 & 2033 6.2. Segment Dashboard 6.3. Asia Pacific Medical Foods Market by Application Outlook 6.4. Chronic Kidney Disease 6.4.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.5. Minimal Hepatic Encephalopathy 6.5.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.6. Chemotherapy Induced Diarrhea 6.6.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.7. Pathogen Related Infections 6.7.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.8. Diabetic Neuropathy 6.8.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.9. ADHD 6.9.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.10. Depression 6.10.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.11. Alzheimer's Disease 6.11.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.12. Nutritional Deficiency 6.12.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13. Orphan Diseases 6.13.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13.2. Tyrosinemia 6.13.2.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13.3. Eosinophilic Esophagitis 6.13.3.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13.4. Food Protein Module-induced enterocolitis syndrome (Food Protein Module-induced enterocolitis syndrome (FPIES)) 6.13.4.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13.5. Phenylketonuria (PKU) 6.13.5.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13.6. Maple syrup urine disease (Maple syrup urine disease (MSUD)) 6.13.6.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13.7. Homocystinuria 6.13.7.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.13.8. Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.) 6.13.8.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.14. Wound Healing 6.14.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.15. Chronic Diarrhea 6.15.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.16. Constipation Relief 6.16.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.17. Protein Booster 6.17.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.18. Dysphagia 6.18.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.19. Pain Management 6.19.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.20. Parkinson's Disease 6.20.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.21. Epilepsy 6.21.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.22. Other Cancer related treatments 6.22.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.23. Severe Protein Allergy 6.23.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.24. Cancer 6.24.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.25. Cachexia 6.25.1. Market estimates and forecast 2021 to 2033 (USD Billion) 6.26. Other (debilitating conditions, COPD, etc.) 6.26.1. Market estimates and forecast 2021 to 2033 (USD Billion) Chapter 7. Asia Pacific Medical Foods Market: Modules Estimates & Trend Analysis 7.1. Modules Market Share, 2025 & 2033 7.2. Segment Dashboard 7.3. Asia Pacific Medical Foods Market by Modules Outlook 7.4. Amino Acid Module 7.4.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.5. Protein Module 7.5.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.6. Vitamin & Mineral Modules 7.6.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.7. Fatty Acid based Modules 7.7.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.8. Carbohydrate Modules 7.8.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.9. Fiber Modules 7.9.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.10. Ketogenic Modules 7.10.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.11. Peptide based Modules 7.11.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.12. Hypoallergic Modules 7.12.1. Market estimates and forecast 2021 to 2033 (USD Billion) 7.13. Others (Electrolyte Module, etc.) 7.13.1. Market estimates and forecast 2021 to 2033 (USD Billion) Chapter 8. Asia Pacific Medical Foods Market: Sales Channel Estimates & Trend Analysis 8.1. Sales Channel Market Share, 2025 & 2033 8.2. Segment Dashboard 8.3. Asia Pacific Medical Foods Market by Sales Channel Outlook 8.4. DTC Sales Channel 8.4.1. Market estimates and forecast 2021 to 2033 (USD Billion) 8.4.2. Online Sales 8.4.2.1. Market estimates and forecast 2021 to 2033 (USD Billion) 8.4.3. Retail Sales 8.4.3.1. Market estimates and forecast 2021 to 2033 (USD Billion) 8.5. Institutional Sales 8.5.1. Market estimates and forecast 2021 to 2033 (USD Billion) 8.5.2. Hospitals 8.5.2.1. Market estimates and forecast 2021 to 2033 (USD Billion) 8.5.3. Others (Long-term Care Facilities, etc.) 8.5.3.1. Market estimates and forecast 2021 to 2033 (USD Billion) Chapter 9. Asia Pacific Medical Foods Market: Country Estimates & Trend Analysis, By Route of Administration, By Product, By Application, By Modules, By Sales Channel 9.1. Country Market Share Analysis, 2025 & 2033 9.2. Country Market Dashboard 9.3. Country Market Snapshot 9.4. Market Size & Forecasts Trend Analysis, 2021 to 2033: 9.5. Asia Pacific 9.5.1. Japan 9.5.1.1. Key country dynamics 9.5.1.2. Regulatory framework 9.5.1.3. Competitive scenario 9.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.2. China 9.5.2.1. Key country dynamics 9.5.2.2. Regulatory framework 9.5.2.3. Competitive scenario 9.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.3. Australia 9.5.3.1. Key country dynamics 9.5.3.2. Regulatory framework 9.5.3.3. Competitive scenario 9.5.3.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.4. India 9.5.4.1. Key country dynamics 9.5.4.2. Regulatory framework 9.5.4.3. Competitive scenario 9.5.4.4. India market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.5. South Korea 9.5.5.1. Key country dynamics 9.5.5.2. Regulatory framework 9.5.5.3. Competitive scenario 9.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.6. Thailand 9.5.6.1. Key country dynamics 9.5.6.2. Regulatory framework 9.5.6.3. Competitive scenario 9.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.7. Vietnam 9.5.7.1. Key country dynamics 9.5.7.2. Regulatory framework 9.5.7.3. Competitive scenario 9.5.7.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.8. Malaysia 9.5.8.1. Key country dynamics 9.5.8.2. Regulatory framework 9.5.8.3. Competitive scenario 9.5.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.9. Singapore 9.5.9.1. Key country dynamics 9.5.9.2. Regulatory framework 9.5.9.3. Competitive scenario 9.5.9.4. Singapore market estimates and forecasts 2021 to 2033 (USD Billion) 9.5.10. Indonesia 9.5.10.1. Key country dynamics 9.5.10.2. Regulatory framework 9.5.10.3. Competitive scenario 9.5.10.4. Singapore market estimates and forecasts 2021 to 2033 (USD Billion) Chapter 10. Competitive Landscape 10.1. Company Categorization 10.2. Company Market Share Analysis at Global and Country Level, 2025 10.3. Company Profiles/Listing 10.3.1. Mead Johnson & Company, LLC 10.3.1.1. Company overview 10.3.1.2. Financial performance 10.3.1.3. Product benchmarking 10.3.1.4. Strategic initiatives 10.3.2. SHS International Ltd 10.3.2.1. Company overview 10.3.2.2. Financial performance 10.3.2.3. Product benchmarking 10.3.2.4. Strategic initiatives 10.3.3. Synutra International Ltd 10.3.3.1. Company overview 10.3.3.2. Financial performance 10.3.3.3. Product benchmarking 10.3.3.4. Strategic initiatives 10.3.4. Milupa Gmbh 10.3.4.1. Company overview 10.3.4.2. Financial performance 10.3.4.3. Product benchmarking 10.3.4.4. Strategic initiatives 10.3.5. Danone 10.3.5.1. Company overview 10.3.5.2. Financial performance 10.3.5.3. Product benchmarking 10.3.5.4. Strategic initiatives 10.3.6. Nestlé 10.3.6.1. Company overview 10.3.6.2. Financial performance 10.3.6.3. Product benchmarking 10.3.6.4. Strategic initiatives 10.3.7. Abbott 10.3.7.1. Company overview 10.3.7.2. Financial performance 10.3.7.3. Product benchmarking 10.3.7.4. Strategic initiatives 10.3.8. Fresenius Kabi AG 10.3.8.1. Company overview 10.3.8.2. Financial performance 10.3.8.3. Product benchmarking 10.3.8.4. Strategic initiatives 10.3.9. GSK plc 10.3.9.1. Company overview 10.3.9.2. Financial performance 10.3.9.3. Product benchmarking 10.3.9.4. Strategic initiatives

圖表清單 List of Tables & Figures

List of Tables Table 1 List of abbreviations Table 2 List of Secondary Sources Table 3 Asia Pacific medical foods market, by region, 2021 - 2033 (USD Billion) Table 4 Asia Pacific medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 5 Asia Pacific medical foods market, by product, 2021 - 2033 (USD Billion) Table 6 Asia Pacific medical foods market, by application, 2021 - 2033 (USD Billion) Table 7 Asia Pacific medical foods market, by modules, 2021 - 2033 (USD Billion) Table 8 Asia Pacific medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 9 Japan medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 10 Japan medical foods market, by product, 2021 - 2033 (USD Billion) Table 11 Japan medical foods market, by application, 2021 - 2033 (USD Billion) Table 12 Japan medical foods market, by modules, 2021 - 2033 (USD Billion) Table 13 Japan medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 14 China medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 15 China medical foods market, by product, 2021 - 2033 (USD Billion) Table 16 China medical foods market, by application, 2021 - 2033 (USD Billion) Table 17 China medical foods market, by modules, 2021 - 2033 (USD Billion) Table 18 China medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 19 Australia medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 20 Australia medical foods market, by product, 2021 - 2033 (USD Billion) Table 21 Australia medical foods market, by application, 2021 - 2033 (USD Billion) Table 22 Australia medical foods market, by modules, 2021 - 2033 (USD Billion) Table 23 Australia medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 24 India medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 25 India medical foods market, by product, 2021 - 2033 (USD Billion) Table 26 India medical foods market, by application, 2021 - 2033 (USD Billion) Table 27 India medical foods market, by modules, 2021 - 2033 (USD Billion) Table 28 India medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 29 South Korea medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 30 South Korea medical foods market, by product, 2021 - 2033 (USD Billion) Table 31 South Korea medical foods market, by application, 2021 - 2033 (USD Billion) Table 32 South Korea medical foods market, by modules, 2021 - 2033 (USD Billion) Table 33 South Korea medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 34 Thailand medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 35 Thailand medical foods market, by product, 2021 - 2033 (USD Billion) Table 36 Thailand medical foods market, by application, 2021 - 2033 (USD Billion) Table 37 Thailand medical foods market, by modules, 2021 - 2033 (USD Billion) Table 38 Thailand medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 39 Vietnam medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 40 Vietnam medical foods market, by product, 2021 - 2033 (USD Billion) Table 41 Vietnam medical foods market, by application, 2021 - 2033 (USD Billion) Table 42 Vietnam medical foods market, by modules, 2021 - 2033 (USD Billion) Table 43 Vietnam medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 44 Malaysia medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 45 Malaysia medical foods market, by product, 2021 - 2033 (USD Billion) Table 46 Malaysia medical foods market, by application, 2021 - 2033 (USD Billion) Table 47 Malaysia medical foods market, by modules, 2021 - 2033 (USD Billion) Table 48 Malaysia medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 49 Indonesia medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 50 Indonesia medical foods market, by product, 2021 - 2033 (USD Billion) Table 51 Indonesia medical foods market, by application, 2021 - 2033 (USD Billion) Table 52 Indonesia medical foods market, by modules, 2021 - 2033 (USD Billion) Table 53 Indonesia medical foods market, by sales channel, 2021 - 2033 (USD Billion) Table 54 Singapore medical foods market, by route of administration, 2021 - 2033 (USD Billion) Table 55 Singapore medical foods market, by product, 2021 - 2033 (USD Billion) Table 56 Singapore medical foods market, by application, 2021 - 2033 (USD Billion) Table 57 Singapore medical foods market, by modules, 2021 - 2033 (USD Billion) Table 58 Singapore medical foods market, by sales channel, 2021 - 2033 (USD Billion) List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Value-chain-based sizing & forecasting Fig. 6 QFD modeling for market share assessment Fig. 7 Market formulation & validation Fig. 8 Asia Pacific medical foods market: market outlook Fig. 9 Parent market outlook Fig. 10 Related/ancillary market outlook Fig. 11 Penetration and growth prospect mapping Fig. 12 Industry value chain analysis Fig. 13 Asia Pacific medical foods market driver impact Fig. 14 Asia Pacific medical foods market restraint impact Fig. 15 Asia Pacific medical foods market strategic initiatives analysis Fig. 16 Asia Pacific medical foods market: Route of administration movement analysis Fig. 17 Asia Pacific medical foods market: Route of administration outlook and key takeaways Fig. 18 Oral market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 19 Enteral market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 20 Asia Pacific medical foods market: Product movement analysis Fig. 21 Asia Pacific medical foods market: Product outlook and key takeaways Fig. 22 Pills market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 23 Powder market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 24 Liquid market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 25 Others (semisolid, semiliquid) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 26 Asia Pacific medical foods market: Application model analysis Fig. 27 Asia Pacific medical foods market: Application model outlook and key takeaways Fig. 28 Chronic kidney disease market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 29 Minimal hepatic encephalopathy market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 30 Chemotherapy induced diarrhea market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 31 Pathogen related infections market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 32 Diabetic neuropathy market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 33 ADHD market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 34 Depression market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 35 Alzheimer's disease market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 36 Nutritional deficiency market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 37 Orphan diseases market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 38 Tyrosinemia market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 39 Eosinophilic Esophagitis market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 40 Food Protein Module-induced enterocolitis syndrome (Food Protein Module-induced enterocolitis syndrome (FPIES)) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 41 Phenylketonuria (PKU) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 42 Maple syrup urine disease (Maple syrup urine disease (MSUD)) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 43 Homocystinuria market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 44 Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 45 Wound healing market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 46 Chronic diarrhea market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 47 Constipation relief market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 48 Protein booster market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 49 Dysphagia market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 50 Pain management market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 51 Parkinson's disease market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 52 Epilepsy market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 53 Other cancer related treatments market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 54 Severe protein allergy market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 55 Cancer market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 56 Chacexia market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 57 Other (debilitating conditions, COPD, etc.) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 58 Asia Pacific medical foods market: Modules model analysis Fig. 59 Asia Pacific medical foods market: Modules model outlook and key takeaways Fig. 60 Amino acid module market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 61 Protein module market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 62 Vitamin & mineral modules market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 63 Fatty acid based modules market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 64 Carbohydrate modules market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 65 Fiber modules market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 66 Ketogenic modules market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 67 Peptide based modules market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 68 Hypoallergic modules market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 69 Others (electrolyte module, etc.) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 70 Asia Pacific medical foods market: Sales channel model analysis Fig. 71 Asia Pacific medical foods market: Sales channel model outlook and key takeaways Fig. 72 DTC sales channel market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 73 Online sales market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 74 Retail sales market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 75 Institutional sales market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 76 Hospitals market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 77 Others (long-term care facilities, etc.) market estimates and forecast, 2021 - 2033 (USD Billion) Fig. 78 Asia Pacific medical foods market: Country movement analysis Fig. 79 Asia Pacific medical foods market: Country outlook and key takeaways Fig. 80 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 81 China Fig. 82 China market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 83 Japan Fig. 84 Japan market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 85 Australia Fig. 86 Australia market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 87 India Fig. 88 India market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 89 South Korea Fig. 90 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 91 Thailand Fig. 92 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 93 Malaysia Fig. 94 Malaysia market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 95 Singapore Fig. 96 Singapore market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 97 Vietnam Fig. 98 Vietnam market estimates and forecasts, 2021 - 2033 (USD Billion) Fig. 99 Indonesia Fig. 100 Indonesia market estimates and forecasts, 2021 - 2033 (USD Billion)

提及公司

Mead Johnson & Company, LLCSHS International LtdSynutra International LtdMilupa GmbhDanoneNestléAbbottFresenius Kabi AGGSK plc

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們